5 Questions That Should Be Asked Regarding GSK126

Most patients reported daily opioids use, mostly for pain at the ulcer site rather than more typical vaso-occlusive pain, consistent with what has been previously reported [23]. This observation suggests that targeted analgesic interventions at the leg ulcer site might have a significant benefit in decreasing patient exposure to systemic opioids [24]. All patients' ulcers had been serially treated with numerous therapies, without sustained improvement, consistent with the lack of effective therapies and evidence-based guidelines on the best therapeutic options [11]. A prothrombotic predisposition is suggested by our data. Factor VIII levels were elevated in most patients; one patient was heterozygous for prothrombin gene mutation and most had borderline low levels of antithrombin http://www.selleckchem.com/products/Cyclopamine.html III. Increased factor VIII levels have been linked with intravascular http://www.selleck.cn/products/gsk126.html hemolysis and chronic inflammation and have been previously recognized to be elevated at steady state in many sickle cell patients [25]. The majority of patients reported a previous history of therapeutic anticoagulation for an earlier thrombotic event and over a third was positive for lupus anticoagulant, a potent risk factor for recurrent thrombosis in patients with a prior history of thrombosis. Few reports exist that focus on the microscopic morphology of skin biopsies in SCD patients with leg ulcers [26-28], and our study offers valuable new insights into their pathophysiology. We describe histopathological evidence of microthrombi and fibrinous deposition on luminal surface of the regional blood vessels in and around the ulcer, to further support the involvement of pathological hemostasis in the ulcerated tissue. We found evidence of remarkably high blood flow in and around the leg ulcer bed, compared to a distant region of the same lower extremity, http://www.selleckchem.com/products/BI-2536.html suggesting that slow healing is not merely due to absent/low skin perfusion. These data are in agreement with previous observations by Mohan et al. in Jamaica, comparing SCD patients with and without ulcers to normal controls [7]. High blood flow in the skin surrounding the ulcer is present in venous ulcers in the general population and is attributed to abnormal cutaneous flow caused by dilation, elongation, and tortuosity of capillaries of the skin [29, 30]. The role of venous incompetence in sickle cell leg ulcer formation has been controverisal, suggested by some investigators [31, 32] and dismissed by others[33, 34]. Lower extremity swelling, induration, discoloration, and the clinical response to compression therapies frequently observed in leg ulcers in SCD patients, favor a role for venous hypertension in these lesions [2, 11].